Table 3.
BMI trend between 5 to 9 years related to bone age in SGA and SRS patients.
| p-values | ||||||||
|---|---|---|---|---|---|---|---|---|
| SRS (23 pt) | 11p15LOM (10 pt) | UPD7 (13 pt) | SGA (21 pt) | SRS vs SGA | 11p15 vs UPD7 | 11p15LOM vs SGA | UPD7 vs SGA | |
| BMI SD at 5y | -2.07 ± 1.16 | -2.58 ± 1.43 | -1.80 ± 0.97 | -1.12 ± 0.98 | 0.90 | 0.33 | 0.09 | 0.18 |
| BMI SD at 7y | -1.48 ± 1.30 | -1.63 ± 1.48 | -1.39 ± 1.25 | -1.41 ± 1.01 | 0.98 | 0.96 | 1 | 0.98 |
| BMI SD at 9y | -0.72 ± 1.39 | -0.40 ± 0.75 | -0.89 ± 1.64 | -0.84 ± 1.46 | 0.85 | 0.28 | 0.35 | 0.70 |
| BMI SD at puberty onset | -0.31 ± 1.09 | 0.46 ± 0.83 | -0.80 ± 0.97 | -0.84 ± 1.20 | 0.20 | 0.04 | 0.03 | 0.85 |
| Δ BMI from 5y to 9y | 1.13 ± 1.02 | 2.3 ± 0.28 | 0.84 ± 0.91 | 0.03 ± 0.98 | 0.04 | 0.09 | 0.07 | 0.11 |
| Δ BMI from 7y to 9y | 0.75 ± 1.04 | 1.47 ± 1.25 | 0.48 ± 0.89 | 0.03 ± 0.36 | 0.06 | 0.08 | 0.007 | 0.31 |
| Bone age-chronological age (at 5/7y) | -1.71 ± 0.81 | -1.32 ± 0.86 | -1.92 ± 0.73 | -1.55 ± 0.95 | 0.79 | 0.26 | 0.61 | 0.46 |
| Bone age-chronological age (at 7/9y) | -1.03 ± 0.97 | -0.33 ± 0.78 | -1.37 ± 0.89 | -1.73 ± 1.24 | 0.15 | 0.05 | 0.04 | 0.46 |
| Bone age-chronological age (at 9/11y) | -0.18 ± 0.98 | -0.57 ± 1.23 | 0.16 ± 0.62 | -1.42 ± 1.25 | 0.007 | 0.14 | 0.38 | 0.001 |
| Δ BA-CA from 5/7y to 9/11y | 2.16 ± 0.86 | 1.7 ± 1.2 | 2.39 ± 0.65 | 0.43 ± 0.9 | 0.001 | 0.71 | 0.08 | 0.001 |
| Δ BA-CA from 7/9y to 9/11y | 1.38 ± 1.02 | 0.78 ± 0.68 | 1.63 ± 1.07 | 0.65 ± 0.52 | 0.08 | 0.38 | 0.78 | 0.04 |
BMI, body mass index; w, weeks; y, years; SGA, small for gestational age; SRS, Silver-Russell syndrome; 11p15, 11p15 loss of methylation; UPD7, maternal uniparental disomy of chromosome 7; BA, bone age; CA, chronological age; Δ, delta.The bold numbers indicate a statically significant p-value ( p value ≤ 0.05).